Drug Type Monoclonal antibody |
Synonyms anti-human CDH3 specific mouse IgG2a antibody (Perseus Proteomics), PPMX-2017 |
Target |
Action inhibitors |
Mechanism CDH3 inhibitors(Cadherin 3 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Lung Cancer | Preclinical | Japan | 15 Apr 2010 |






